(Q36689044)

15 August 2017

1 reference

title

Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues (English)

1 reference

15 August 2017

Ali D Kamal

1

1 reference

15 August 2017

Stephen C Bain

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Expert Opinion on Drug Safety

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

5-7

1 reference

Efficacy and safety of insulin glulisine in patients with type 1 diabetes

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.1.5

Insulin glulisine provides improved glycemic control in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.1.5

Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.1.5

Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.1.5

Insulin glulisine--a comprehensive preclinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.1.5

Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.1.5

21 January 2018

Identifiers

DOI

10.1517/14740338.6.1.5

1 reference

15 August 2017

1 reference